| Net Cash Provided by (Used in) Operating Activities |
$18,937 |
USD |
14% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$20,000 |
USD |
-17% |
Q3 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q3 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
250,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Shares, Issued |
1,272,917 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$1,063 |
USD |
-43% |
Q3 2025 |
Q1 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$13,181 |
USD |
59% |
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$2,446,660 |
USD |
-0.63% |
Q2 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$2,450,000 |
USD |
-0.41% |
Q2 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
100,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Authorized |
10,000,000 |
shares |
0% |
Q3 2025 |
Q1 2026 |
| Additional Paid in Capital |
$11,628,209 |
USD |
0.68% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Shares Outstanding |
100,000 |
shares |
|
Q3 2025 |
Q1 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$2,446,660 |
USD |
-0.63% |
Q2 2025 |
FY 2025 |
| Interest Expense |
$90 |
USD |
43% |
Q3 2025 |
Q1 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
Q1 2026 |